Adma Biologics (ADMA) Revenue Growth (1y) (2012 - 2025)
Adma Biologics (ADMA) Revenue Growth (1y) (2012 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Revenue Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
37.90% |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
64.24% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
7.82% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Adma Biologics |
1.98 Bn |
1.89 Bn |
88.82 Mn |
18.39% |
| Date | Value |
|---|
| Dec 31, 2025 |
18.39% |
| Sep 30, 2025 |
12.00% |
| Jun 30, 2025 |
13.80% |
| Mar 31, 2025 |
40.22% |
| Dec 31, 2024 |
59.06% |
| Sep 30, 2024 |
8.94% |
| Jun 30, 2024 |
78.29% |
| Mar 31, 2024 |
43.86% |
| Dec 31, 2023 |
47.86% |
| Sep 30, 2023 |
167.70% |
| Jun 30, 2023 |
-19.84% |
| Mar 31, 2023 |
95.56% |
| Dec 31, 2022 |
-9.12% |
| Sep 30, 2022 |
98.69% |
| Jun 30, 2022 |
320.63% |
| Mar 31, 2022 |
81.34% |
| Dec 31, 2021 |
294.09% |
| Sep 30, 2021 |
101.24% |
| Jun 30, 2021 |
128.96% |
| Mar 31, 2021 |
57.34% |
